Associated Vitreoretinal and Uveitis Consultants

06/05/2026

Our team of sub-specialty-trained retina specialists provides advanced care for a wide range of retinal conditions. Learn more about our patient-centered approach to diagnosis and treatment: https://brnw.ch/21x36q0

06/02/2026

Beep Baseball is an adaptive sport designed for individuals who are blind or visually impaired, promoting teamwork, competition, and community. Learn more about how this unique game supports active living and engagement beyond vision loss: https://brnw.ch/21x31KR

2026 marks 50 years of play.

05/28/2026

The first quarter of 2026 saw developments in ophthalmology, including new treatments for presbyopia, age-related macular degeneration, dry eye disease, glaucoma, corneal dystrophy, geographic atrophy, and new intraocular lenses. These advancements highlight ongoing progress in protecting and improving vision. Learn more: https://brnw.ch/21x2TVP

Q1 2026 eye-care roundup: first dual-agent presbyopia drop, new EDOF IOL, wet AMD phase 3 win, and gene-therapy advances.

05/26/2026

Your first visit is designed to make you feel informed and supported every step of the way. From evaluations and imaging to treatments or procedures, the care team works closely with you to create a personalized plan and ensure the best possible outcomes. Learn more: https://brnw.ch/21x2PJg

05/21/2026

Our team is proud to be members of leading professional organizations, including the American Society of Retina Specialists, American Academy of Ophthalmology, Indiana Academy of Ophthalmology, and American Uveitis Society. These affiliations support ongoing learning and excellence in patient care.

05/20/2026

A study by NovaBridge Biosciences and Visara highlights promising early results in retinal diseases like wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Emerging treatments may improve outcomes while reducing treatment burden for patients. Learn more: https://brnw.ch/21x2DMk

The phase 2a study looks at retinal vascular diseases, including wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO).

05/15/2026

We’re excited to welcome patients to our new Greenfield location opening next week, expanding access to advanced retina care for even more communities across Indiana. Visit us at 2243 Barrett Drive, Suite C, Greenfield, IN 46140, for the expert treatment and trusted specialty care you count on. Learn more: https://brnw.ch/21x2wlp

05/14/2026

Clear communication and thoughtful care can make a meaningful difference in a patient’s experience. Supporting patients throughout their journey remains a priority for us!

05/13/2026

New research in age-related macular degeneration (AMD) shows progress in slowing disease progression. Emerging therapies may offer new options for patients in the future. Learn more: https://brnw.ch/21x2r4h

Phase 2 ArMaDa data show statistically significant 31% reduction in GA lesion growth with OCU410 at 12 months, with a favorable safety profile supporting phase 3 development.

05/07/2026

Our blog explores the differences between wet and dry age-related macular degeneration (AMD) and why regular monitoring is crucial to protect vision. While both impact central vision, they progress differently and require regular monitoring to help protect sight. Learn more: https://brnw.ch/21x2hdH